DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02186 LUYE PHARMA

Closed Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. L & M Index, HS Comp. MidCap Ind, HS Comp. M & S Index, Stock Connect HK Ind, Stock Connect HK MS
Major Shareholders LIU Dian Bo & Associates (33.13%)
Hillhouse Investment Management, Ltd. (14.68%)		 Sector Health Care & Biotechnology
Web Site http://www.luye.cn Tel (852) 3523-0428
Email luye@luye.cn Fax (852) 3523-0430
Related Equities N/A
Principal Activities Principally engaged in developing, producing, marketing and selling innovative pharmaceutical products in the PRC.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Ginkgo (PTC) Limited 1,517,113,930(L) 74,740,909(S)  46.32(L) 2.28(S)  21/12/2018
Luye Life Sciences Group Ltd 1,517,113,930(L) 74,740,909(S)  46.32(L) 2.28(S)  21/12/2018
刘殿波 1,517,113,930(L) 74,740,909(S)  46.32(L) 2.28(S)  21/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
刘殿波 1,517,113,930(L) 74,740,909(S)  46.32(L) 2.28(S)  21/12/2018
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top